{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:44:07Z","timestamp":1761569047063,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clgc.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T22:50:01Z","timestamp":1530139801000},"page":"e1117-e1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?"],"prefix":"10.1016","volume":"16","author":[{"given":"Niraj","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mythri","family":"Mudireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rangit","family":"Vallapureddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-1411","authenticated-orcid":false,"given":"Nelson","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4215-6500","authenticated-orcid":false,"given":"Thomas","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-8735","authenticated-orcid":false,"given":"Fang-Shu","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3940-7284","authenticated-orcid":false,"given":"Tamas","family":"Ordog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinal","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Houston","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebede","family":"Begna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2018.06.008_bib1","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1158\/1078-0432.CCR-14-0494","article-title":"Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2018.06.008_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13045-015-0180-y","article-title":"Role of DNA methylation in renal cell carcinoma","volume":"8","author":"Shenoy","year":"2015","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.clgc.2018.06.008_bib3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/annonc\/mdw241","article-title":"Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective","volume":"27","author":"Shenoy","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2018.06.008_bib4","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","article-title":"Aberrant DNA methylation is a dominant mechanism in MDS progression to AML","volume":"113","author":"Jiang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clgc.2018.06.008_bib5","first-page":"103175","article-title":"The epigenetic landscape of acute myeloid leukemia","volume":"2014","author":"Conway O'Brien","year":"2014","journal-title":"Adv Hematol"},{"key":"10.1016\/j.clgc.2018.06.008_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/epi.7.2.19015","article-title":"Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia","volume":"7","author":"Yamazaki","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.clgc.2018.06.008_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.82","article-title":"Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clgc.2018.06.008_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.21562","article-title":"Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms","volume":"85","author":"Hussein","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clgc.2018.06.008_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: emerging patterns and implications","volume":"13","author":"Feil","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.clgc.2018.06.008_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.leukres.2011.06.001","article-title":"Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry","volume":"35","author":"Neukirchen","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.clgc.2018.06.008_bib11","first-page":"1704","article-title":"Racial\/ethnic and gender disparities in renal cell carcinoma incidence and survival","volume":"179","author":"Stafford","year":"2008","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.06.008_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1464-410X.2007.07268.x","article-title":"An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications","volume":"101","author":"Choueiri","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2018.06.008_bib13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3109\/10428194.2011.603443","article-title":"Association between non-Hodgkin lymphoma and renal cell carcinoma","volume":"52","author":"Lossos","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clgc.2018.06.008_bib14","first-page":"714","article-title":"Coincident renal cell carcinoma and nonHodgkin's lymphoma: the M. D. Anderson experience and review of the literature","volume":"159","author":"Anderson","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.06.008_bib15","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2325::AID-CNCR22>3.0.CO;2-Y","article-title":"Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence?","volume":"77","author":"Tihan","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2018.06.008_bib16","first-page":"1925","article-title":"Characteristics of patients diagnosed with both melanoma and renal cell cancer","volume":"24","author":"Abern","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clgc.2018.06.008_bib17","first-page":"900","article-title":"Second primary malignancies associated with renal cell carcinoma histological subtypes","volume":"176","author":"Thompson","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2018.06.008_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ymgme.2015.07.004","article-title":"Biology of the bone marrow microenvironment and myelodysplastic syndromes","volume":"116","author":"Rankin","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clgc.2018.06.008_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exphem.2006.08.017","article-title":"Enhanced growth of myelodysplastic colonies in hypoxic conditions","volume":"35","author":"Thompson","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.clgc.2018.06.008_bib20","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3109\/10428194.2012.696637","article-title":"Hypoxia-inducible factor-1alpha expression indicates poor prognosis in myelodysplastic syndromes","volume":"53","author":"Tong","year":"2012","journal-title":"Leuk Lymphoma"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318300569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767318300569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:30:56Z","timestamp":1761564656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767318300569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1558767318300569"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2018.06.008","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}